Literature DB >> 22212641

Different NF-κB activation characteristics of human respiratory syncytial virus subgroups A and B.

Weining Wu1, Andrew Macdonald, Julian A Hiscox, John N Barr.   

Abstract

Human respiratory syncytial virus (HRSV) is a member of the family Paramyxoviridae, and is responsible for serious respiratory illness in infants, the elderly and the immunocompromised. HRSV exists as two distinct lineages known as subgroups A and B, which represent two lines of divergent evolution with extensive genetic and serologic differences. While both subgroup A and B viruses contribute to overall HRSV disease, subgroup A isolates are associated with both increased frequency and morbidity of infections, and reasons for this are unclear. HRSV disease is characterized by virus-mediated cell destruction in combination with extensive inflammatory and immune modulatory responses, and for HRSV subgroup A isolates, several of these signaling pathways are regulated through activation of the transcription factor NF-κB. In contrast, the NF-κB activation characteristics of HRSV subgroup B infection remain untested. Here, we performed a quantitative and comparative analysis of NF-κB activation in response to infection of both continuous and primary cell cultures with HRSV subgroup A and B isolates. Our results showed the model HRSV subgroup A isolate consistently induced increased NF-κB activation compared to its HRSV subgroup B counterpart. The differential NF-κB activation characteristics of HRSV subgroup A and B viruses may contribute to differences in their pathogenesis.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22212641     DOI: 10.1016/j.micpath.2011.12.006

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  6 in total

1.  [Epidemiological characteristics of respiratory syncytial virus in hospitalized children with acute lower respiratory tract infection in Chongqing, China, from 2013 to 2018: an analysis of 2 066 cases].

Authors:  Kang-Yi Ren; Luo Ren; Yu Deng; Xiao-Hong Xie; Na Zang; Jun Xie; Zheng-Xiu Luo; Jian Luo; Zhou Fu; EnMei Liu; Qu-Bei Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-01

Review 2.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

3.  Characteristics and Their Clinical Relevance of Respiratory Syncytial Virus Types and Genotypes Circulating in Northern Italy in Five Consecutive Winter Seasons.

Authors:  Susanna Esposito; Antonio Piralla; Alberto Zampiero; Sonia Bianchini; Giada Di Pietro; Alessia Scala; Raffaella Pinzani; Emilio Fossali; Fausto Baldanti; Nicola Principi
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

4.  Respiratory Syncityal Virus A and B: three bronchiolitis seasons in a third level hospital in Italy.

Authors:  C Ciarlitto; A C Vittucci; L Antilici; C Concato; C Di Camillo; P Zangari; A Villani
Journal:  Ital J Pediatr       Date:  2019-08-28       Impact factor: 2.638

5.  High Resolution Analysis of Respiratory Syncytial Virus Infection In Vivo.

Authors:  Waleed Aljabr; Stuart Armstrong; Natasha Y Rickett; Georgios Pollakis; Olivier Touzelet; Elaine Cloutman-Green; David A Matthews; Julian A Hiscox
Journal:  Viruses       Date:  2019-10-10       Impact factor: 5.048

6.  Host and Viral Factors in Respiratory Syncytial Virus Infection.

Authors:  Peter Mastrangelo; Richard G Hegele
Journal:  Curr Pediatr Rep       Date:  2013-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.